Valuation: Becton, Dickinson and Company

Market Cap 48.16B 42.91B 39.99B 36.42B 68.65B 4,638B 69.07B 483B 188B 2,365B 181B 177B 7,603B P/E 2026 *
34.1x
P/E 2027 * 19x
Enterprise Value 64.04B 57.07B 53.19B 48.43B 91.3B 6,167B 91.86B 642B 250B 3,145B 240B 235B 10,111B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 3.15x
Free-Float
73.18%
Yield 2026 *
2.22%
Yield 2027 * 2.26%
1 day+2.19%
1 week-1.71%
Current month+0.93%
1 month-2.20%
3 months+14.29%
6 months+16.93%
Current year-6.90%
1 week 175.71
Extreme 175.71
182.95
1 month 175.2
Extreme 175.2
186.63
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%-1.71%-6.68%-30.44% 48.16B
+2.67%-1.17%-25.63%+4.65% 169B
+1.84%-0.76%-9.96%+15.34% 110B
+3.55%+4.72%-23.02%+7.15% 106B
+1.19%+0.42%-48.90%-11.41% 73.87B
+1.90%+2.61%+4.02%+72.41% 58.98B
+1.32%+4.32%+14.41%+64.37% 51.28B
+1.67%+1.50%-16.50%+21.67% 40.84B
+1.80%+0.32%+29.60%-0.91% 32.21B
+0.53%+3.17% - - 31.24B
Average +1.87%-0.51%-9.18%+15.87% 72.14B
Weighted average by Cap. +2.14%-1.13%-15.26%+13.55%

Financials

2026 *2027 *
Net sales 19.28B 17.18B 16.01B 14.58B 27.48B 1,856B 27.65B 193B 75.18B 947B 72.37B 70.8B 3,043B 19.74B 17.59B 16.39B 14.93B 28.14B 1,901B 28.31B 198B 76.98B 969B 74.1B 72.49B 3,116B
Net income 1.44B 1.28B 1.19B 1.09B 2.05B 138B 2.06B 14.41B 5.6B 70.55B 5.39B 5.28B 227B 2.34B 2.08B 1.94B 1.77B 3.34B 225B 3.36B 23.47B 9.12B 115B 8.78B 8.59B 369B
Net Debt 15.88B 14.15B 13.19B 12.01B 22.65B 1,530B 22.78B 159B 61.95B 780B 59.63B 58.34B 2,508B 13.95B 12.43B 11.59B 10.55B 19.89B 1,344B 20.01B 140B 54.41B 685B 52.38B 51.24B 2,203B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-10-05 $180.67 +2.19% 1,603,493
26-10-02 $176.80 -0.71% 1,865,274
26-10-01 $178.07 -0.52% 1,287,879
26-09-30 $179.00 -1.63% 1,798,603
26-09-29 $181.97 -1.01% 1,534,743
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
176.80USD
Average target price
196.50USD
Spread / Average Target
+11.14%

Quarterly revenue - Rate of surprise